The test identifies how your body responds to semaglutide and other peptides before you start therapy, enabling personalized dosing and medication selection
PlexusDx patients typically start at 0.25 mcg weekly and increase by 0.25 mcg every 4 weeks (weeks 1-4: 0.25 mcg, weeks 5-8: 0.5 mcg, weeks 9-12: 1.0 mcg) until reaching your target maintenance dose between 1.0-2.4 mcg weekly
Each transfer of bacteriostatic water, each vial swirl, and each draw into a syringe carries a small volumetric variance, commonly estimated at 510% per step in non-calibrated lab work [estimate, unverified]
Most orders are processed within 24 hours
Rare but serious side effects can occur with GLP 1 medicines, and our pharmacy team will go through these with you and remain available for support throughout treatment
For peptide-based medications, including receptor agonists that target metabolic pathways, half-life plays a critical role